Correction to: Heat Shock Protein 90 Stimulates Rat Mesenchymal Stem Cell Migration via PI3K/Akt and ERK1/2 Pathways (Cell Biochemistry and Biophysics, (2015), 71, 1, (481-489), 10.1007/s12013-014-0228-6);Heat Shock Protein 90 Stimulates Rat Mesenchymal Stem Cell Migration via PI3K/Akt and ERK1/2 Pathways

Cell Biochemistry and Biophysics

Volumn 71, Issue 1, 2015, Pages 481-489

  Gao, Feng ^a,b   Hu, Xinyang ^a   Xie, Xiaojie ^a   Liu, Xianbao ^a   Wang, Jianan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Cytokines; Heat shock protein; Mesenchymal stem cell; Migration

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, RAT; GELATINASE A; GELATINASE B; HEAT SHOCK PROTEIN 90; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL; CELL MOTION; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; CELL MOVEMENT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MESENCHYMAL STROMAL CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CXCR4; RECOMBINANT PROTEINS; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84921938855     PISSN: 10859195     EISSN: 15590283     Source Type: Journal    
DOI: 10.1007/s12013-019-00878-1     Document Type: Erratum

References (42)

1. Majumdar, M. K., Thiede, M. A., Haynesworth, S. E., Bruder, S. P., & Gerson, S. L. (2000). Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. Journal of Hematotherapy & Stem Cell Research,9(6), 841–848.
2. Wright, V., Peng, H., Usas, A., et al. (2002). BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Molecular Therapy,6(2), 169–178.
3. Mizuno, K., Muneta, T., Morito, T., et al. (2008). Exogenous synovial stem cells adhere to defect of meniscus and differentiate into cartilage cells. Journal of Medical and Dental Sciences,55(1), 101–111.
4. Li, Y., Yu, J., Li, M., Qu, Z., & Ruan, Q. (2011). Mouse mesenchymal stem cells from bone marrow differentiate into smooth muscle cells by induction of plaque-derived smooth muscle cells. Life Sciences,88(3–4), 130–140.
5. Wang, Q. W., Chen, Z. L., & Piao, Y. J. (2005). Mesenchymal stem cells differentiate into tenocytes by bone morphogenetic protein (BMP) 12 gene transfer. Journal of Bioscience and Bioengineering,100(4), 418–422.
6. Elabd, C., Chiellini, C., Carmona, M., et al. (2009). Human multipotent adipose-derived stem cells differentiate into functional brown adipocytes. Stem Cells,27(11), 2753–2760.
7. Psaltis, P. J., Zannettino, A. C., Worthley, S. G., & Gronthos, S. (2008). Concise review: Mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells,26(9), 2201–2210.
8. Marenzi, G., & Bartorelli, A. L. (2007). Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. European Heart Journal,28(17), 2172–2173. author reply 2173–2174.
9. Fuh, E., & Brinton, T. J. (2009). Bone marrow stem cells for the treatment of ischemic heart disease: A clinical trial review. Journal of Cardiovascular Translational Research,2(2), 202–218.
10. Barbash, I. M., Chouraqui, P., Baron, J., et al. (2003). Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation,108(7), 863–868.
11. Langer, T., Rosmus, S., & Fasold, H. (2003). Intracellular localization of the 90 kDA heat shock protein (HSP90alpha) determined by expression of a EGFP-HSP90alpha-fusion protein in unstressed and heat stressed 3T3 cells. Cell Biology International,27(1), 47–52.
12. Yano, A., Tsutsumi, S., Soga, S., et al. (2008). Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone. Proceedings of the National Academy of Sciences of the United States of America,105(40), 15541–15546.
13. Wu, L. X., Xu, J. H., Huang, X. W., Zhang, K. Z., Wen, C. X., & Chen, Y. Z. (2006). Down-regulation of p210(bcr/abl) by curcumin involves disrupting molecular chaperone functions of Hsp90. Acta Pharmacologica Sinica,27(6), 694–699.
14. Zsebik, B., Citri, A., Isola, J., Yarden, Y., Szollosi, J., & Vereb, G. (2006). Hsp90 inhibitor 17-AAG reduces ErbB2 levels and inhibits proliferation of the trastuzumab resistant breast tumor cell line JIMT-1. Immunology Letters,104(1–2), 146–155.
15. Giaccone, G., & Rajan, A. (2009). Met amplification and HSP90 inhibitors. Cell Cycle,8(17), 2682.
16. Grammatikakis, N., Lin, J. H., Grammatikakis, A., Tsichlis, P. N., & Cochran, B. H. (1999). p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function. Molecular and Cellular Biology,19(3), 1661–1672.
17. Sidera, K., Gaitanou, M., Stellas, D., Matsas, R., & Patsavoudi, E. (2008). A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2. Journal of Biological Chemistry,283(4), 2031–2041.
18. Tsutsumi, S., Scroggins, B., Koga, F., et al. (2008). A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene,27(17), 2478–2487.
19. Gao, F., Hu, X. Y., Xie, X. J., et al. (2010). Heat shock protein 90 protects rat mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis via the PI3K/Akt and ERK1/2 pathways. Journal of Zhejiang University-Science B,11(8), 608–617.
20. Xie, X. J., Wang, J. A., Cao, J., & Zhang, X. (2006). Differentiation of bone marrow mesenchymal stem cells induced by myocardial medium under hypoxic conditions. Acta Pharmacologica Sinica,27(9), 1153–1158.
21. Heussen, C., & Dowdle, E. B. (1980). Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Analytical Biochemistry,102(1), 196–202.
22. Baer, P. C., & Geiger, H. (2010). Mesenchymal stem cell interactions with growth factors on kidney repair. Current Opinion in Nephrology and Hypertension,19(1), 1–6.
23. Walsh, D., Li, Z., Wu, Y., & Nagata, K. (1997). Heat shock and the role of the HSPs during neural plate induction in early mammalian CNS and brain development. Cellular and Molecular Life Sciences,53(2), 198–211.
24. Lesko, E., Gozdzik, J., Kijowski, J., Jenner, B., Wiecha, O., & Majka, M. (2007). HSP90 antagonist, geldanamycin, inhibits proliferation, induces apoptosis and blocks migration of rhabdomyosarcoma cells in vitro and seeding into bone marrow in vivo. Anti-Cancer Drugs,18(10), 1173–1181.
25. Minami, Y., Kawasaki, H., Miyata, Y., Suzuki, K., & Yahara, I. (1991). Analysis of native forms and isoform compositions of the mouse 90-kDa heat shock protein, HSP90. Journal of Biological Chemistry,266(16), 10099–10103.
26. Nemoto, T., & Sato, N. (1998). Oligomeric forms of the 90-kDa heat shock protein. Biochemical Journal,330(Pt 2), 989–995.
27. Grenert, J. P., Sullivan, W. P., Fadden, P., et al. (1997). The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation. Journal of Biological Chemistry,272(38), 23843–23850.
28. Basso, A. D., Solit, D. B., Chiosis, G., Giri, B., Tsichlis, P., & Rosen, N. (2002). Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. Journal of Biological Chemistry,277(42), 39858–39866.
29. Roe, S. M., Ali, M. M., Meyer, P., et al. (2004). The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37). Cell,116(1), 87–98.
30. Sato, S., Fujita, N., & Tsuruo, T. (2000). Modulation of Akt kinase activity by binding to Hsp90. Proceedings of the National Academy of Sciences of the United States of America,97(20), 10832–10837.
31. Abi-Younes, S., Sauty, A., et al. (2000). The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circulation Research,86(2), 131–138.
32. Yamaguchi, J., Kusano, K. F., et al. (2003). Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation,107(9), 1322–1328.
33. Oberlin, E., Amara, A., et al. (1996). The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature,382(6594), 833–835.
34. Jo, D. Y., Rafii, S., et al. (2000). Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. Journal of Clinical Investigation,105(1), 101–111.
35. Lima e Silva, R., Shen, J., et al. (2007). The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization. FASEB Journal,21(12), 3219–3230.
36. Abbott, J. D., Huang, Y., et al. (2004). Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation,110(21), 3300–3305.
37. Guo, Y., Hangoc, G., et al. (2005). SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells. Stem Cells,23(9), 1324–1332.
38. Shao, H., Tan, Y., et al. (2008). Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels. Stem Cells,26(5), 1376–1384.
39. Hyun, Y. M., Chung, H. L., et al. (2009). Activated integrin VLA-4 localizes to the lamellipodia and mediates T cell migration on VCAM-1. The Journal of Immunology,183(1), 359–369.
40. Bowden, R. A., Ding, Z. M., et al. (2002). Role of alpha4 integrin and VCAM-1 in CD18-independent neutrophil migration across mouse cardiac endothelium. Circulation Research,90(5), 562–569.
41. Matsuura, K., Honda, A., et al. (2009). Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. Journal of Clinical Investigation,119(8), 2204–2217.
42. Lu, L., Zhang, J. Q., et al. (2004). Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissue. Biochemical and Biophysical Research Communications,320(3), 907–913.